These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39181599)
1. MEST promotes immune escape in gastric cancer by downregulating MHCI expression via SHP2. Huang M; Zhang F; Zhu Y; Zeng H; Li S Int J Biochem Cell Biol; 2024 Sep; 174():106621. PubMed ID: 39181599 [TBL] [Abstract][Full Text] [Related]
2. Asiaticoside promoted ferroptosis and suppressed immune escape in gastric cancer cells by downregulating the Wnt/β-catenin pathway. Ye C; Yao Z; Wang Y; Zhang C Int Immunopharmacol; 2024 Jun; 134():112175. PubMed ID: 38733821 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA MIR17HG reduced tumorigenicity and Treg-mediated immune escape of non-small-cell lung cancer cells through targeting the miR-17-5p/RUNX3 axis. Zheng G; Ye H; Bai J; Zhang X J Biochem Mol Toxicol; 2024 May; 38(5):e23715. PubMed ID: 38704830 [TBL] [Abstract][Full Text] [Related]
4. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells. Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816 [TBL] [Abstract][Full Text] [Related]
5. Cancer cell-derived exosomal circUSP7 induces CD8 Chen SW; Zhu SQ; Pei X; Qiu BQ; Xiong D; Long X; Lin K; Lu F; Xu JJ; Wu YB Mol Cancer; 2021 Nov; 20(1):144. PubMed ID: 34753486 [TBL] [Abstract][Full Text] [Related]
6. CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. Li Y; Wang Z; Gao P; Cao D; Dong R; Zhu M; Fei Y; Zuo X; Cai J J Transl Med; 2024 Jul; 22(1):704. PubMed ID: 39080693 [TBL] [Abstract][Full Text] [Related]
7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094 [No Abstract] [Full Text] [Related]
8. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer. Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597 [TBL] [Abstract][Full Text] [Related]
9. FOXA1/UBE2T Inhibits CD8 Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180 [TBL] [Abstract][Full Text] [Related]
10. H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p/lactate dehydrogenase A axis. Sun L; Li J; Yan W; Yao Z; Wang R; Zhou X; Wu H; Zhang G; Shi T; Chen W Cancer Sci; 2021 Jun; 112(6):2245-2259. PubMed ID: 33756038 [TBL] [Abstract][Full Text] [Related]
11. M-CSF secreted by gastric cancer cells exacerbates the progression of gastric cancer by increasing the expression of SHP2 in tumor-associated macrophages. Zhang S; Ren D; Hou H; Yao L; Yuan H Aging (Albany NY); 2023 Dec; 15(24):15525-15534. PubMed ID: 38159254 [TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1. Tian P; Wei JX; Li J; Ren JK; Yang JJ Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543 [TBL] [Abstract][Full Text] [Related]
13. APLNR inhibited nasopharyngeal carcinoma growth and immune escape by downregulating PD-L1. Liu Y; Li N; Guo Y; Zhou Q; Yang Y; Lu J; Tian Z; Zhou J; Yan S; Li X; Shi L; Jiang S; Ge J; Feng R; Huang D; Zeng Z; Fan S; Xiong W; Li G; Zhang W Int Immunopharmacol; 2024 Aug; 137():112523. PubMed ID: 38909500 [TBL] [Abstract][Full Text] [Related]
14. TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway. Xue F; Liu L; Tao X; Zhu W J Gynecol Oncol; 2024 Sep; 35(5):e64. PubMed ID: 38456588 [TBL] [Abstract][Full Text] [Related]
15. PRMT6 Promotes the Immune Evasion of Gastric Cancer by Upregulating ANXA1. Xu L; Zhang F; Yu B; Jia S; Fan S Crit Rev Eukaryot Gene Expr; 2024; 34(5):69-79. PubMed ID: 38842205 [TBL] [Abstract][Full Text] [Related]
16. N Tang B; Bi L; Xu Y; Cao L; Li X Mol Biotechnol; 2024 Oct; 66(10):2850-2859. PubMed ID: 37817028 [TBL] [Abstract][Full Text] [Related]
17. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells. Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263 [TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation. Miao Z; Li J; Wang Y; Shi M; Gu X; Zhang X; Wei F; Tang X; Zheng L; Xing Y Mol Cancer; 2023 Dec; 22(1):205. PubMed ID: 38093288 [TBL] [Abstract][Full Text] [Related]
19. SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability Yuan Y; Fan Y; Gao Z; Sun X; Zhang H; Wang Z; Cui Y; Song W; Wang Z; Zhang F; Niu R Cancer Biol Med; 2020 Aug; 17(3):707-725. PubMed ID: 32944401 [No Abstract] [Full Text] [Related]
20. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis. Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]